{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:11:14Z","timestamp":1765289474099,"version":"3.46.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ucl.2025.09.004","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:23:29Z","timestamp":1761654209000},"page":"65-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging of Clinically Localized Prostate Cancer"],"prefix":"10.1016","volume":"53","author":[{"given":"Arman S.","family":"Walia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ucl.2025.09.004_bib1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.004_bib2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.21037\/tau.2017.05.06","article-title":"Diffusion weighted imaging of the prostate\u2014principles, application, and advances","volume":"6","author":"Maurer","year":"2017","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.004_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1102\/1470-7330.2006.0021","article-title":"Diffusion-weighted magnetic resonance imaging and its application to cancer","volume":"6","author":"Charles-Edwards","year":"2006","journal-title":"Cancer Imaging"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.004_bib4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00261-015-0589-3","article-title":"DCE MRI of prostate cancer","volume":"41","author":"Berman","year":"2016","journal-title":"Abdom Radiol N Y"},{"author":"Kasivisvanathan","key":"10.1016\/j.ucl.2025.09.004_bib5"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.004_bib6","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3390\/cancers15041280","article-title":"Micro-ultrasound: current role in prostate cancer diagnosis and future possibilities","volume":"15","author":"Basso Dias","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.004_bib7","doi-asserted-by":"crossref","first-page":"34.e27","DOI":"10.1016\/j.urolonc.2013.01.006","article-title":"High-resolution transrectal ultrasound: pilot study of a novel technique for imaging clinically localized prostate cancer","volume":"32","author":"Pavlovich","year":"2014","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.004_bib8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.juro.2015.12.093","article-title":"Assessing cancer risk on novel 29 MHz micro-ultrasound images of the prostate: creation of the micro-ultrasound protocol for prostate risk identification","volume":"196","author":"Ghai","year":"2016","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.004_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41585-024-00900-z","article-title":"Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer","volume":"22","author":"Bakht","year":"2025","journal-title":"Nat Rev Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.004_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41391-023-00755-2","article-title":"Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET\/CT imaging of prostate cancer\u2014a systematic review and meta-analysis","volume":"27","author":"Huang","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.004_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.004_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3348\/kjr.2009.10.3.244","article-title":"Classification of focal prostatic lesions on transrectal ultrasound (TRUS) and the Accuracy of TRUS to Diagnose Prostate Cancer","volume":"10","author":"Lee","year":"2009","journal-title":"Korean J Radiol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.004_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2214\/ajr.174.3.1740623","article-title":"Using gray-scale and color and power Doppler sonography to detect prostatic cancer","volume":"174","author":"Halpern","year":"2000","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.004_bib14","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233337","article-title":"Update on PI-RADS Version 2.1 diagnostic performance benchmarks for prostate MRI: systematic review and meta-analysis","volume":"312","author":"Oerther","year":"2024","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.ucl.2025.09.004_bib15","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3390\/cancers14071828","article-title":"Multiparametric magnetic resonance imaging grades the aggressiveness of prostate cancer","volume":"14","author":"Morote","year":"2022","journal-title":"Cancers"},{"issue":"10071","key":"10.1016\/j.ucl.2025.09.004_bib16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ucl.2025.09.004_bib17","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ucl.2025.09.004_bib18","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ucl.2025.09.004_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000004069","article-title":"The genomics and natural history of MRI-Visible vs MRI-invisible prostate cancers: clinical implications","author":"Klotz","year":"2024","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.004_bib20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ijc.34743","article-title":"Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis","volume":"154","author":"Lehto","year":"2024","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.004_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1148\/radiol.212163","article-title":"Comparison of Micro-US and multiparametric MRI for prostate cancer detection in biopsy-naive men","volume":"305","author":"Ghai","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.ucl.2025.09.004_bib22","article-title":"Prostate mapping for cancer diagnosis: the madrid protocol. transperineal prostate biopsies using multiparametric magnetic resonance imaging fusion and micro-ultrasound guided biopsies","author":"Socarr\u00e1s","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.09.004_bib23","article-title":"Microultrasonography-guided vs MRI-guided biopsy for prostate cancer diagnosis: the OPTIMUM randomized clinical trial","volume":"23","author":"Kinnaird","year":"2025","journal-title":"JAMA"},{"author":"Arora","key":"10.1016\/j.ucl.2025.09.004_bib24"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.004_bib25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a Prospective Multicentre Study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.ucl.2025.09.004_bib26","first-page":"1644","article-title":"The PRIMARY score: using intraprostatic 68Ga-PSMA PET\/CT patterns to optimize prostate cancer diagnosis","volume":"63","author":"Emmett","year":"2022","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.ucl.2025.09.004_bib27","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ucl.2025.09.004_bib28","first-page":"1","article-title":"Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer","author":"Incesu","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.004_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","volume":"84","author":"Chow","year":"2023","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.004_bib30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bju.15152","article-title":"Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging 68 Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant?","volume":"126","author":"Chen","year":"2020","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.004_bib31","first-page":"193.e19","article-title":"Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI","volume":"43","author":"Sundaresan","year":"2025","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.004_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.eururo.2019.10.007","article-title":"Randomized study of systematic biopsy versus magnetic resonance imaging and targeted and systematic biopsy in men on active surveillance (ASIST): 2-year Postbiopsy Follow-up","volume":"77","author":"Klotz","year":"2020","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.004_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eururo.2024.03.014","article-title":"PRECISE Version 2: updated recommendations for reporting prostate magnetic resonance imaging in patients on active surveillance for prostate cancer","volume":"86","author":"Englman","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2025.09.004_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.euros.2022.09.019","article-title":"Micro-ultrasound versus magnetic resonance imaging in prostate cancer active surveillance","volume":"46","author":"Albers","year":"2022","journal-title":"Eur Urol Open Sci"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.004_bib35","first-page":"76","article-title":"A systematic review on prostate-specific membrane antigen positron emission tomography (PSMA PET) evaluating localized low- to intermediate-risk prostate cancer: a tool to improve risk stratification for active surveillance?","volume":"14","author":"Liu","year":"2024","journal-title":"Life Basel Switz"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.004_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2214\/AJR.17.18757","article-title":"Preoperative prostate MRI: a road map for surgery","volume":"211","author":"McEvoy","year":"2018","journal-title":"Am J Roentgenol"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.004_bib37","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/j.1743-6109.2012.02794.x","article-title":"Use of Multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve-sparing radical prostatectomy","volume":"9","author":"Panebianco","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.ucl.2025.09.004_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2025.02.002","article-title":"Preoperative magnetic resonance imaging membranous urethral length as a predictor of urinary continence after radical prostatectomy: a systematic review and meta-analysis","author":"Negrean","year":"2025","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.004_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.euo.2023.07.004","volume":"7","author":"Nguyen","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.004_bib40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.juro.2015.02.080","article-title":"Image guided focal therapy for magnetic resonance imaging visible prostate cancer: defining a 3-dimensional treatment margin based on magnetic resonance imaging histology co-registration analysis","volume":"194","author":"Le Nobin","year":"2015","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.004_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.prnil.2022.08.004","article-title":"Irreversible electroporation for prostate cancer using PSMA PET-CT","volume":"11","author":"Shin","year":"2023","journal-title":"Prostate Int"},{"author":"Albers","key":"10.1016\/j.ucl.2025.09.004_bib42"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.004_bib43","first-page":"1251","article-title":"Prostate MRI in stereotactic body radiation treatment planning and delivery for localized prostate cancer","volume":"42","author":"Nigogosyan","year":"2022","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"issue":"7","key":"10.1016\/j.ucl.2025.09.004_bib44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME Randomized Phase III Trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.004_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2967\/jnumed.117.197160","article-title":"The Impact of 68Ga-PSMA PET\/CT on management intent in prostate cancer: results of an australian prospective multicenter study","volume":"59","author":"Roach","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ucl.2025.09.004_bib46","doi-asserted-by":"crossref","DOI":"10.1053\/j.semnuclmed.2025.03.006","article-title":"Impact of PSMA PET on radiation oncology planning","author":"Spohn","year":"2025","journal-title":"Semin Nucl Med"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.004_bib47","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.240269","article-title":"Multiparametric MRI before and after focal therapy for prostate cancer: pearls and pitfalls for the reporting radiologist","volume":"7","author":"Lai","year":"2025","journal-title":"Radiol Imaging Cancer"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.004_bib48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.euo.2023.04.007","article-title":"Prostate Imaging after Focal Ablation (PI-FAB): a proposal for a scoring system for multiparametric MRI of the prostate after focal therapy","volume":"6","author":"Giganti","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.004_bib49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2024.02.001","article-title":"The transatlantic recommendations for prostate gland evaluation with magnetic resonance imaging after focal therapy (TARGET): a systematic review and international consensus recommendations","volume":"85","author":"Light","year":"2024","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.004_bib50","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2967\/jnumed.118.221564","article-title":"68Ga-PSMA-11 PET\/MR detects local recurrence occult on mpMRI in prostate cancer patients after HIFU","volume":"60","author":"Burger","year":"2019","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.004_bib51","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.euo.2021.01.003","article-title":"Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international Consensus -based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy","volume":"4","author":"Panebianco","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.004_bib52","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2019.11.001","article-title":"A Prospective Study of 18F-DCFPyL PSMA PET\/CT restaging in recurrent prostate cancer following primary external beam radiotherapy or brachytherapy","volume":"106","author":"Liu","year":"2020","journal-title":"Int J Radiat Oncol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:06:18Z","timestamp":1765289178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014325000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0094014325000874"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2025.09.004","relation":{},"ISSN":["0094-0143"],"issn-type":[{"type":"print","value":"0094-0143"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging of Clinically Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2025.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}